FDA Adverse Event Malfunction Summary report: N

COAGUCHEK® XS SYSTEM

MDR report key: 1710449 · Received June 4, 2010

Report

Report Number
1823260-2010-03364
Event Type
Malfunction
Date Received
June 4, 2010
Date of Event
May 27, 2010
Report Date
July 8, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

A PHYSICIAN'S OFFICE REPORTED THAT COMPARISON TESTS WERE PERFORMED USING CONTOUR AND A COMPETITOR'S METER. THE CONTOUR READ IN THE 101-108 MG/DL RANGE, WHILE THE OTHER METER READ IN THE 200 MG/DL RANGE. DEPENDING ON THE READINGS OF THE COMPETITOR'S METER, THE DIFFERENCE COULD FALL IN THE "C" ZONE OF THE CONSENSUS ERROR GRID, MAKING THE DIFFERENCE CLINICALLY SIGNIFICANT. NO ADVERSE EVENTS WERE ALLEGED. NO OTHER INFO WAS PROVIDED ABOUT THIS EVENT.

Description of Event or Problem · 1

CALLER STATES PATIENT TESTED 7.4 INR ON THE COAGUCHEK XS SYSTEM WHILE A COMPARISON LAB RETURNED AS 4.6 INR. PATIENT'S COUMADIN DOSE WAS HELD FOR 2 DAYS BASED ON METER AND LAB VALUES. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 20179331

Patients

Seq Age Sex Outcome Treatment
1 061 YR CARDIZEM| DIOVAN HCT| LIPITOR| COUMADIN DAILY